Search

A study by UT Southwestern neurology researchers found that Hispanic people have lower-quality outcomes than white people among ischemic stroke patients who receive endovascular thrombectomies. Racial disparities were not found between Black and white patients.

A UT Southwestern researcher who studies how the body’s innate immune system responds to coronaviruses is one of 10 recipients of the coveted NIH Director’s Pioneer Award from the National Institutes of Health.

If not teamed with psychological, social, and emotional support, cancer news can negatively impact young patients’ emerging developmental needs and perspectives.

Two UTSW faculty elected to prestigious National Academy of Sciences

Peter O’Donnell Jr., whose committed humanitarianism, legendary generosity, and cherished friendship graced UT Southwestern Medical Center for many decades, passed away at the age of 97.

Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than 20% higher risk of heart attack or stroke over the following 10 years, according to findings from a multicenter study led by preventive cardiologists at UT Southwestern Medical Center.

UT Southwestern researchers report the first structural confirmation that endogenous – or self-made – molecules can set off innate immunity in mammals via a pair of immune cell proteins called the TLR4-MD-2 receptor complex.

A new approach that targets the cellular machinery that viruses need to reproduce – rather than the virus itself – appears to stem replication of a common childhood pathogen known as respiratory syncytial virus (RSV), UT Southwestern researchers report in a new study.

Mechanical hearts spur some regeneration in dormant parts of failing hearts, according to a UT Southwestern pilot study that shows promise for developing regenerative heart therapies.

A first-in-kind immune-modulating drug that arose from decades of basic research at UT Southwestern Medical Center has received approval from the U.S. Food and Drug Administration as a new treatment for myasthenia gravis.